𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Metastatic renal cell carcinoma to the nose and paranasal sinuses

✍ Scribed by Ricard Simo; Andrew J. Sykes; Simon P. Hargreaves; Patrick R. Axon; Andrew R. Birzgalis; Nick J. Slevin; W. Trevor Farrington

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
174 KB
Volume
22
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Surgical resection of metastatic renal c
Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy
✍ Dr. Richard M. Shery; Harvey I. Pass; Steven A. Rosenberg; James C. Yang πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 473 KB πŸ‘ 2 views

Thirty-one patients with disseminated melanoma or renal cell cancer (RCC) who had a limited relapse or persistent disease after a partial or complete response to interleukin-2 (IL-z)-based immunotherapy underwent resection of progressing tumors or residual sites of disease. There were no surgery-rel

A phase II study of constant-infusion fl
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma
✍ Mary J. Wilkinson; John W. Frye; Eric J. Small; Alan P. Venook; Peter R. Carroll πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 347 KB πŸ‘ 2 views

Background. Twenty-nine patients with metastatic renal cell carcinoma (RCC) were treated with constantinfusion floxuridine (FUdR, Roche Laboratories, Nut-Methods. The initial dosage was 0.075 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025-mg/kg/day increments at each sub